MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 6,880.00
-60.00 (-0.86%)
Dec 10, 2025, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 235.81 billion as of December 10, 2025. Its market cap has increased by 46.91% in one year.
Market Cap
235.81B
Enterprise Value
194.27B
Revenue
2.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,880.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 235.81B, a decrease of -34.95%. That is a compound annual growth rate of -6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 237.87B | 56.48% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | 2.39T | 435.67% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.84T |
| Celltrion | 40.98T |
| ALTEOGEN | 24.44T |
| SK Biopharmaceuticals | 10.58T |
| ABL Bio | 10.26T |
| Yuhan | 8.70T |
| LigaChem Biosciences | 6.67T |
| Peptron | 6.54T |